Debra A. Gordon
Senior VP & Chief Legal CounselDr. Debra A. Gordon, also known as Deb, Ph.D., J.D., as served as Senior Vice President and Chief Legal Counsel of HTG Molecular Diagnostic Inc since June 2011. Prior to joining HTG, Dr. Gordon was General Counsel and Head, Patent Legal at Ventana, a medical diagnostics company and a member of the Roche Group and the global headquarters for RTD, from October 2008 to June 2011. Dr. Gordon was promoted to leadership of the Ventana legal function after serving at Ventana from February 2007 as a patent attorney supporting the assay development functions. For nearly ten years preceding Dr. Gordon’s in-house legal experiences, Dr. Gordon practiced as a business transactional attorney at the law firms Lewis and Roca LLP (now, Lewis Roca Rothgerber LLP) and Perkins Coie LLP and as an intellectual property attorney at the law firm Klarquist Sparkman LLP. Prior to law school, Dr. Gordon completed post-doctoral fellowships at Brandeis University and the University of Arizona. Dr. Gordon is an author on 13 peer-reviewed scientific publications and an inventor on two patent filings and one issued U.S. patent. Dr. Gordon received a B.S. in Biology and Chemistry and a M.S. in Chemistry from Western Washington University, a Ph.D. in Physiology from the University of Arizona, College of Medicine and a J.D. with honors from the University of Arizona, James E. Rogers College of Law.
Positions
- Company NameHTG Molecular Diagnostics, Inc.Stock CodeHTGMQPositionSenior VP & Chief Legal CounselColleagues
- JLJohn L. LubniewskiPresident, CEO & Director
- AFAnn F. HanhamIndependent Chairman of the Board
- LLLaura Lee GodlewskiSenior Vice President of Finance & Administration
- PCPatrick C. RocheSenior Vice President of Research & Development
- SAStephen A. BaratSenior Vice President of Therapeutics
- CPChristopher P. KiritsyNon-Employee Independent Director
- LRLee R. McCrackenIndependent Director
- MGMichelle GriffinIndependent Director
